Noevir N5 | Zinc Oxide, Octinoxate, Titanium Dioxide Powder Breastfeeding
Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Noevir N5 | Zinc Oxide, Octinoxate, Titanium Dioxide Powder while breastfeeding. We will also discuss about common side effects and warnings associated with Noevir N5 | Zinc Oxide, Octinoxate, Titanium Dioxide Powder.

Can I continue breastfeeding if I am using Noevir N5 | Zinc Oxide, Octinoxate, Titanium Dioxide Powder? How long does it stays in breast milk?

Noevir N5 | Zinc Oxide, Octinoxate, Titanium Dioxide Powder high risk while breastfeeding
There are total 3 active ingredients in Noevir N5 | Zinc Oxide, Octinoxate, Titanium Dioxide Powder which makes it a complicated task to assess the effect of Noevir N5 | Zinc Oxide, Octinoxate, Titanium Dioxide Powder on breastfeeding. Here on drlact after analyzing all 3 ingredients we have reached on conclusion that Noevir N5 | Zinc Oxide, Octinoxate, Titanium Dioxide Powder is unsafe in breastfeeding. Below is our summarized analysis of Zinc oxide, Octinoxate, Titanium dioxide.

Noevir N5 | Zinc Oxide, Octinoxate, Titanium Dioxide Powder Breastfeeding Analsys


Zinc oxide while Breastfeeding

Safe

CAS Number: 1314-13-2

It is used topically as an astringent and skin protector, very often together with small amounts of Ferric Oxide to form Calamine (see specific info). It is a product compatible with breastfeeding according to WHO Essential Medicine’s List - 2002.It is also used in dental hygiene products and cosmetics. Widely used for skin protection of the diaper area in infants. Because of the small dose used and poor absorption into plasma of most topical dermatological preparations, excretion into breastmilk in significant amount appears to be unlikely. Do not apply on the breast to prevent infant ingestion; otherwise, wash it off thoroughly with water before the next breast feed.


Noevir N5 | Zinc Oxide, Octinoxate, Titanium Dioxide Powder Breastfeeding Analsys - 2


Octinoxate and Breastfeeding

Unsafe

Is Noevir N5 | Zinc Oxide, Octinoxate, Titanium Dioxide Powder safe while breastfeeding

Octinoxate (Octylmethoxycinnamate) has been detected in human urine, blood and breast milk and is known for moderate risk of skin allergy. Some studies suggest that Octinoxate has estrogen like effects however less than 1% skin penetration has been found in human laboratory studies. As not much study has been done on effects of Octinoxate during breast feeding its recommended to use safe alternatives.

Octyl Methoxycinnamate (OMC) is a frequently used UV-filter in sunscreens and other cosmetics. Octinoxate can be systemically absorbed after skin application, being found in the deeper layers of the stratum corneum as well as urine, plasma, and breast milk. The mean maximum plasma concentration detected after application of 2mg/cm2 sunscreen was 7ng/mL in women and 16ng/mL in men. FDA study found blood levels 13 times above cutoff for systemic exposure.

Several studies indicated that OMC acts as an endocrine disruptor due to the ability to interfere with endocrine system at different levels. In humans OMC exposure has minor, but statistically significant effects on the levels of testosterone and estradiol. Moreover, some studies suggested that OMC can interact with the hypothalamo-pituitary-thyroid (HPT) axis.

Moreover, a study of offspring of dams treated with OMC (500�1000 mg/kg/day) showed sex-dependent behavioral changes, namely decreased motor activity in females, but not in males, and improved spatial learning in males, suggesting that OMC can affect neuronal development, however the doses used in these experiments were extremely high, not relevant to possible human exposure.

Note: Study and data for tropical use only

Warning: High dosage shall be avoided as reproductive system, thyroid and behavioral alterations in animal studies has been found, Tropical usage in breast area shall be avoided to prevent the OCTINOXATE passing orally in Infants.

Titanium dioxide and Breastfeeding

Low Risk

Not much study has been done on effects of topical usage of Titanium Dioxide during breast feeding but as there is no finding of Titanium Dioxide passing in breast milk its unlikely to cause any health issue for infant.

Some animal studies suggest that maternal exposure to titanium dioxide nanoparticles during pregnancy and lactation alters offspring hippocampal mRNA BAX and Bcl-2 levels, induces apoptosis and decreases neurogenesis. But dosage was significantly higher than daily possible exposure to humans.

Note: Study and data for tropical use only. Inhalation concerns in powder or spray products.

Warning: Tropical usage in breast area shall be avoided to prevent the Titanium Dioxide passing orally in Infants. Titanium dioxide is possibly carcinogenic to humans. Titanium dioxide can be drastically more harmful if used as powder or spray as risk of inhalation can increase significantly.


What should I do if already breastfed my kid after using Noevir N5 | Zinc Oxide, Octinoxate, Titanium Dioxide Powder?

If you observer abnormal behavior or any other health issue in infant then you should immediately call 911 or contact other contact other emergency service provider in your area otherwise closely monitor the baby and inform your doctor about your Noevir N5 | Zinc Oxide, Octinoxate, Titanium Dioxide Powder usage and time interval of breastfeeding.


My health care provider has asked me to use Noevir N5 | Zinc Oxide, Octinoxate, Titanium Dioxide Powder, what to do?

If your doctor knows that you are breastfeeding mother and still prescribes Noevir N5 | Zinc Oxide, Octinoxate, Titanium Dioxide Powder then there must be good reason for that as Noevir N5 | Zinc Oxide, Octinoxate, Titanium Dioxide Powder is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Noevir N5 | Zinc Oxide, Octinoxate, Titanium Dioxide Powder, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Noevir N5 | Zinc Oxide, Octinoxate, Titanium Dioxide Powder and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Noevir N5 | Zinc Oxide, Octinoxate, Titanium Dioxide Powder in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients